AlphaCrest Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-15,488
| Closed | -$148K | – | 566 |
|
|
2022
Q3 | $148K | Buy |
15,488
+2,803
| +22% | +$26.8K | 0.01% | 1246 |
|
|
2022
Q2 | $140K | Sell |
12,685
-4,853
| -28% | -$53.6K | 0.01% | 1224 |
|
|
2022
Q1 | $292K | Buy |
17,538
+1,838
| +12% | +$30.6K | 0.02% | 1110 |
|
|
2021
Q4 | $300K | Buy |
15,700
+4,287
| +38% | +$81.9K | 0.01% | 1256 |
|
|
2021
Q3 | $281K | Buy |
+11,413
| New | +$281K | 0.01% | 1130 |
|
|
2021
Q2 | – | Sell |
-12,900
| Closed | -$408K | – | 1287 |
|
|
2021
Q1 | $408K | Buy |
12,900
+800
| +7% | +$25.3K | 0.02% | 897 |
|
|
2020
Q4 | $561K | Buy |
12,100
+1,100
| +10% | +$51K | 0.05% | 588 |
|
|
2020
Q3 | $362K | Buy |
+11,000
| New | +$362K | 0.04% | 771 |
|
|
2020
Q2 | – | Sell |
-9,500
| Closed | -$284K | – | 1003 |
|
|
2020
Q1 | $284K | Buy |
+9,500
| New | +$284K | 0.03% | 820 |
|
|
2019
Q4 | – | Sell |
-12,000
| Closed | -$218K | – | 1305 |
|
|
2019
Q3 | $218K | Buy |
+12,000
| New | +$218K | 0.01% | 1191 |
|